Drug therapy
Immunomodulator therapy
Passive immunization
|
|
|
Ocrelizumab therapy (procedure)
Ocrelizumab therapy
Id
860788002
Status
Defined
Direct substance
Ocrelizumab
Has intent
Therapeutic
Method
Administration - action